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ABSTRACT 
 
The determinants of public health care expenditure are examined in two of the most 
decentralized countries in the world (Canada and Spain) for two partly overlapping 
time-spans of data availability: Canada, 1981 to 2013 and Spain, 2002 to 2013.  
While Canada generally spends more per capita on health care than Spain, over time 
Spain’s macro level health indicator performance has surpassed Canada’s.  Using 
regression analysis, we find the key determinants of public health care spending 
include time trend, income, physician numbers and regional fixed effects.  Physician 
numbers are a significant driver of real per capita public health expenditures in 
Canada but not Spain despite the greater per capita number of physicians in Spain.  
Differences in the growth and performance of real per capita income explain much 
of the gap between public health spending between these two countries with some 
contribution from differences in per capita physician numbers.  The differential 
health indicator outcomes raise the question of what Canada might do to be more 
efficient. 
JEL Classification:  H51, I1, I18, I3 
Keywords: Health care expenditure, Canada, Spain, panel data, income elasticity 
 
 
Key Points: 
 
Canada's health spending is less sensitive to income than Spain’s.  
 
Physician numbers are a more important driver of health expenditures in Canada 
but not in Spain. 
 
Aging is not a major driver of spending in either Canada or Spain  
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 I. Introduction 
 
Canada and Spain are developed economies with modern public health care systems 
and substantial differences in the per capita level of health care spending as well as 
the health outcomes (1,2,3,4). Canada spends more per capita on health and yet in 
terms of basic macro level health indicator performance, Spain has gradually 
overtaken Canada. The share of health spending accounted for by the public sector 
is equivalent in Canada and Spain at approximately 70 per cent.  Therefore, we 
examine the determinants of public sector health expenditure in Canada and Spain 
to see the differences in the contributions of key health expenditure drivers that 
might explain some of this differential expenditure performance. 
 
Both Canada and Spain are highly decentralized countries though Canada is a 
federation while Spain remains a unitary state.  Canada and Spain differ in terms of 
economic characteristics, geographic span and age composition.  According to data 
from the IMF World Economic Outlook Database, in 2017, per capita GDP in Canada 
was USD 44,773 while Spain’s was lower at USD 28,212.  Canada’s unemployment 
rate in 2017 was 6.5 percent compared to 17 percent for Spain.  Part of this 
differential economic performance can be attributed to the fact that Spain was hit 
much harder than Canada by the 2008-09 global economic crisis and its recovery 
has been much slower [ 5,6]. 
 
Furthermore, Spain’s population is larger at 46.333 million compared to 36.638 
million for Canada [7] and is also more densely populated given its much smaller 
geographic area compared to Canada.  As well, in 2016 Spain has a more aged 
population with 19 percent of its population over age 65 compared to 17 percent for 
Canada.1  Needless to say, these differences could also be factors explaining 
differences in their per capita public health spending which in 2015 according to the 
OECD was $3,262 in Canada and $2204 in Spain (US PPP dollars) [8]. 
 
                                                        
1
 See https://data.worldbank.org/indicator/SP.POP.65UP.TO.ZS 
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When it comes to health spending and delivery, both countries have relatively 
decentralized regional health care expenditure and delivery systems but with 
differences in funding models and aspects of service provision like accessibility to 
private services. Another interesting difference between Canada and Spain in terms 
of their health systems is with respect to physician intensity – that is, Canada has 
fewer physicians per capita than Spain, despite the economic crisis and austerity 
policies in the European Union (5,6).   
 
The remainder of the paper is structured as follows. We first briefly describe the 
features of the Canadian and Spanish health care systems in Section II. Next, section 
III surveys the related literature on health care expenditure determinants and its 
dynamics. Section IV provides an overview of the empirical model and a brief 
description of the data. Section V presents the results derived from the model. The 
final section summarizes and concludes. 
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II. Health Systems and Health Care in Decentralized Countries: The Case of 
Canada and Spain 
 
Health care in Canada is both publically and privately financed. However, it should 
be noted that public finance does not entail direct provision of health services by 
government. Canadian physicians, for example, are almost completely publicly 
financed, but physicians are considered private contractors who bill the public 
health funder with their compensation still based mainly on fee for service.2 
Nevertheless, about 30 percent of health expenditure in Canada is privately funded 
and the remainder publically funded with the proportion varying both by province 
and by expenditure category with public shares the largest in hospital and physician 
services [9].3   
 
As a result of its federal nature, Canada does not have one public health care system, 
but 14 publicly funded systems, given there are ten provinces, three territories and 
a federal government.4 In Canada, both the federal and provincial governments 
finance public health spending but it is provincial governments who administer 
publicly funded health care making the system quite decentralized with some 
variation in service provision.  At the same time, within each province it is a single 
payer system and as a result the actual delivery of public health care is actually quite 
centralized within each respective jurisdiction. 
 
Provincial and territorial government health expenditures are for insured health 
services and extended health care and are financed by own source revenues as well 
                                                        
2
 While Canadian physicians are still overwhelmingly on Fee for Service with prices for services negotiated 
between provincial medical association and provincial government health ministries, recent years have seen 
the introduction of new approaches. Enhanced Fee for Service combines fee for service with bonuses or 
block grants to achieve some type of performance target. There is also what is known as Alternative 
Payment Programs which provides bonuses or other financial incentives for practicing in certain regions or 
meeting other performance criteria. Capitation has also become of increasing importance in recent years. 
3
 It should be noted that the provisions of the Canada Health Act are a reason for these large shares in 
physician and hospital spending. 
4
 It should also be noted that direct health expenditures by the Canadian federal government are relatively 
small and directed towards First Nations and the Armed Forces. 
Determinants of Public Health Expenditures 
 5 
as federal government transfers to the provinces.  Federal transfers for provincial-
territorial government health spending are made according to the legislation of the 
1984 Canada Health Act, which specifies the general criteria which provinces and 
territories are expected to meet to receive full federal health transfers.5  In 2015-
2016, the total value of the Canada Health Transfer to the provincial and territorial 
governments was $CAD 34 billion dollars and is expected to increase to $CAD 37.2 
billion by 2017-2018.6 Federal transfers provide about 20 to 25 percent of 
provincial government health expenditures though the growth rate of these 
transfers will decline after 2017.7 
 
According to the Canadian Institute for Health Information, total health 
expenditures in Canada was forecast to reach $CAD 242 billion in 2017 up from 
$CAD 233 billion the year previous. Provincial-territorial health spending is forecast 
to be $CAD 157 billion in 2017 up from $152 billion in 2016.  Average provincial-
territorial government real per capita health spending (in 1997 dollars) has risen 
from $CAD 1,203 in 1975 and projected at $CAD 2,483 in 2016 though this spending 
has been declining since 2010 when it stood at $CAD 2,577.  One view (10: xvii-xviii) 
notes that: “… Canada - like most advanced industrial countries - appears to have 
entered a new phase of dampened [health spending] growth since the fiscal crisis 
and recession of 2008-09.” Health spending in Canada both total and public sector 
has also been declining as a share of GDP over the last few years [9].  
 
The public share of health spending in Spain is equivalent to Canada at 
approximately 71 percent according to the most recent OECD Health Statistics 
numbers but is down from an early 1980s peak of over 80 percent.  The Spanish 
health care system has seen a change from a Social Security model to a National 
                                                        
5
 Briefly, the key criteria of the Canada Health Act include that provincial health systems must be 
publically administered, be comprehensive in their coverage of insured services, must be universal in their 
coverage, must have portable benefits and must provide for reasonable access to insured services. 
6
  Department of Finance. Federal Support to Provinces and Territories. http://www.fin.gc.ca/fedprov/mtp-
eng.asp.  
7
 The 6 percent escalator of the 2004 Health Accord is being replaced by a formula based on the growth 
rate of real GDP subject to a 3 percent floor. 
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Health System (NHS, from the 1986 Health Act). This has been accompanied by a set 
of reforms that introduced quasi-market mechanisms into the health system.  
 
The Spanish NHS is based on the principle of universalism (basic coverage for all 
residents). General Practitioner (GP) and paediatricians (primary care) are the first 
contact point of patients with NHS. Their choice is possible (if the physician’s list has 
not reached the maximum number of allowed patients), but access to specialist care 
services (secondary care) is restricted by gate-keeping system. Once the GP has 
authorized the visit or procedure, patients are free to choose any provider among 
those accredited by the NHS inside their origin region and a special health care fund 
exists for displaced patients.  Moreover, because of waiting lists, as in other 
European countries (e.g. Italy, Greece, Portugal, etc.), some individuals consult 
private specialists at their own expense in order to complement public health 
insurance.  
 
Health care is decentralised to regions with financing via regional and shared taxes 
and block-grants from the central government. Pharmaceutical co-payments are 
used as additional source of financing and to discourage inappropriate use. 
Inpatient care and primary care are free at the point of health utilization. In 
emergency cases, direct and free access is allowed for all health care services, 
regions and population groups.  Like other OECD countries, health care 
decentralization in terms of regional systems has been seen as a way to improve 
responsiveness and efficiency. As a result of these processes, Spain –much like 
Canada -- does not really have one public health care system, but 17 publicly funded 
systems, given that there are 17 autonomous communities (regions) along with a 
federal government.  At the same time, much like the Canadian system within each 
region there is a single payer system for public health spending. 
 
Regional governments  in Spain organize their own health care services as recently 
demonstrated [4,11,12] and as a result, there are differences across regions mainly 
in complementary supply and coverage of (and access to) some health care 
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programs.  For example, in the case of dental care in Spain, most of the assistance is 
carried out through private systems with public sector performance limited to 
diagnosis and pain relief through dental extraction for adults, and preventive 
programs of conservative dentistry for children and adolescents.  
 
Comparisons of performance and spending across the Canadian and Spanish health 
care systems are provided in Figures 1-4. Figure 1 plots per capita total and public 
health spending in US $ PPP (Purchasing Power Parity) for Canada and Spain for the 
period 1960 to 2015 using OECD data.8  Per capita health spending has grown in 
both countries over time, but growth rates have declined over time with Spain hit 
harder after the 2008-09 recession.   
 
There has been a persistent gap in health spending between the two countries.  In 
1965, total per capita health spending (US $PPP) was $163 in Canada and $39 in 
Spain while public health spending was $86 and $15 respectively.  By 2015, total per 
capita health spending (US $PPP) was $4,608 in Canada and $3,153 in Spain while 
public per capita health spending was $3,262 and $2,204 respectively.  With respect 
to public health care spending, in 2015 Canada spent approximately 48 percent 
more than Spain.   
 
Despite the considerably larger per capita amounts being spent by Canada relative 
to Spain, it is interesting that physician density is now greater in Spain as illustrated 
in Figure 2.  By 2014, there were 2.6 physicians per 1,000 of population in Canada as 
opposed to 3.8 in Spain – Spain having 46 percent more physicians per 1,000 of 
population.  
 
Also, as illustrated in both Figures 3 and 4, over time, the performance of the 
Spanish health care system in terms of basic health indicators improved faster than 
Canada’s and indeed overtaken the Canadian system. Life expectancy has grown, 
                                                        
8
 OECD Health Statistics 2015 and 2016 [8] 
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and infant mortality fallen in both Canada and Spain over the last half century.  
However, whereas Spanish life expectancy at birth was below that of Canadians in 
the 1960s, by 2011 it was 1.3 percent higher (82.6 versus 81.5 years).9  Meanwhile, 
while infant mortality in Spain was 60 percent higher in Spain relative to Canada in 
1960 (at 43.7 versus 27.3 deaths per 1,000 live births), by 2012, it was actually 35 
percent lower in Spain (at 3.1 versus 4.8 deaths per 1,000 births).10 
 
Given the Canada spends considerably more per capita on health care than Spain 
but with similar public shares, undertanding the source of expenditure differences is 
of interest given that higher spending and lower heath indicator outcomes in 
Canada suggest differences in the cost-effectiveness of the two systems. Spain 
spends less per capita and yet appears to have better performance.  Our next step is 
to compare the deteminants of public health expenditure across the two countries 
to see what the sources of the expenditure differential might be. 
  
                                                        
9
 These life expectancy numbers are from OECD Health Statistics 2017.  It should be noted that in 
developed countries, values for life expectancy tend to be similar and as a result small differences in actual 
values can generate large differences in rankings. 
10
 These numbers are again taken from OECD Health Statistics 2017 but it should be noted that the 
definition of infant mortality depends on the definition of live births and that can vary internationally.   
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Figure 1 
 
Per Capita Health Spending in Canada & Spain, 1960-2015 (US PPP$; OECD 
Health Statistics 2017) 
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Figure 2 
 
Physicians, Density per 1,000 Population (Source: OECD Health Statistics 
2017) 
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Figure 3 
 
Life Expectancy at Birth, Years, Total Population (Source: OECD Health 
Statistics 2017) 
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Figure 4 
 
Infant Mortality, Deaths Per 10000 Live Births (Source: OECD Health Statistics 
2017) 
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III. Health Expenditure Determinants  
 
The health expenditure determinants literature identifies key drivers as physician 
numbers, population growth, population aging, income, inflation, and enrichment 
factors such as technological extension. Studies have used international, national 
and regional level data to examine the determinants of health expenditures with 
simple bivariate cross-sectional techniques, multivariate regression, pooled time 
series regressions, error-correction approaches as well as non-parametric 
techniques [1,2,3,4,13,14,15,17]. Moreover, recently micro-data has also been 
utilized in an effort to determine expenditure determinants at an individual rather 
than aggregate level. All of these studies use a “determinants” approach in which per 
capita health care expenditures are regressed on variables believed to affect health 
expenditures.  
 
Income is seen as the key factor in explaining health care spending and health 
spending’s sensitivity to income – the elasticity of health expenditure – crucial in 
determining whether health spending is a necessity or a luxury.   High income 
elasticities are seen as an indicator of health spending as a luxury good even though 
common perceptions maintain that health care is a necessity [18].  Yet, the view of 
health as a ‘luxury” may be the result of econometric specifications11  with Sen [19] 
emphasizing omitted variable bias, unobserved country and year specific effects as 
the main factors.  Getzen [20] argues the data source can be a source of the 
differences with individual income elasticities closer to zero and national health 
expenditure income elasticities being often larger than one.  
 
Leu using 19 OECD countries found income elasticities ranging from 1.18 to 1.36 
[21].  Parkin, McGuire and Yule [22] used similar methods and data found income 
elasticities of between 1.12 to 1.18 while Brown [23] obtained an income elasticity 
of 1.39.  Gerdtham et al [14] used a cross-section of 19 OECD countries and also 
                                                        
11
 Culyer [18] (p.46) argues that the missing variable is probably “too subtle to be readily 
quantified.”  It may be in the public budgeting mechanism used to fund health care. 
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reported a large income elasticity of 1.33 while Gbsesmete and Gerdtham [24] used 
a cross-sectional sample of 30 African countries and reported an income elasticity 
slightly less than 1.  
 
Studies using pooled time-series cross-sectional data for either countries or regions 
find income or GDP a significant determinant of health spending but usually with 
lower income elasticity estimates.  Hitiris and Posnett [16] used 560 pooled time-
series and cross-section observations from 20 OECD countries over the period 
1960-87 and found an income elasticity close to one.  Barros [17] used data for 24 
OECD countries for the period 1960 to 1992 and also found an income elasticity 
close to one.  Gerdtham, et al. (15) used a pooled time-series cross-section analysis 
for 22 countries over the period 1970-1991 and found the income elasticity of 
health expenditure to be in the 0.7-0.8 range. An exception to these income inelastic 
results done using data for 10 OECD countries from 1960-1991 found the income 
elasticity of health expenditure ranged from 1.14 to 1.17 [25]. 
 
In a national-level pooled time-series cross-section Canadian provincial study, Di 
Matteo and Di Matteo (1) found an income elasticity of 0.77.  Di Matteo (26,27) using 
non-parametric approaches for Canadian, OECD and US data finds that income 
elasticities are higher at low-income levels and decline with rising income. As well, 
income elasticity does vary by level of analysis with international income elasticities 
being larger than national or regional studies.  Bilgel and Tran in their examination 
of Canadian provincial level find that the long run income elasticity of health 
expenditure is substantially lower than one [28]. 
 
López-Casasnovas and Saez [29] using data for 110 regions in eight OECD countries 
and a multilevel hierarchical model concluded that the degree of fiscal 
decentralization within countries in estimating income elasticity of health 
expenditure could be important although in a framework of more regional 
decentralization, public policies aimed at increasing choice and competition also 
may tend to rise national health care expenditure.  A panel of US state level data 
Determinants of Public Health Expenditures 
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controlling for the proportion of the population over the age of 65, urbanization and 
hospital beds [30] found the cross-section income elasticity of health care around 
0.7. Hartwig and Sturm [31] using 33 OECD countries over the period 1970 to 2010 
find GDP growth a robust and statistically significant determinant of health care 
expenditure growth.  Ang [32] examines health care expenditure in Australia during 
the period 1960–2003 and finds the income elasticity for health care is found to be 
greater than one, suggesting that health care is a luxury good.  
 
The time-series literature has been criticized on the basis of the issue of stationarity 
and a co-integration approach applied.12  In a national-level study, Murthy and 
Ukpolo [41] applied co-integration techniques to time-series data for the United 
States over the period 1960-87 and found the income elasticity of health care 
spending not significantly different from one.  Ariste and Carr [42] used error 
correction and co-integration techniques on Canadian provincial health expenditure 
data (1966-1998) and found an income elasticity of 0.88.  Murthy and Okunade [43] 
apply a Autoregressive Distributed Lag Cointegration (ARDL) approach to US annual 
time series data from 1960 to 2012 and find an income elasticity estimate of around 
0.92 and that medical technology advances play a major role in the long run rise of 
the U.S. health expenditure. 
 
Time series tests for stationarity can often yield inconclusive results and this has 
sometimes been the case in health expenditure determinants studies.  Gerdtham and 
Jonsson [13: 48] note methodological differences are the most likely reason for 
diffrences in results and the reliability of the tests is an issue.  Nonetheless, even 
with this caveat it remains that the results from the time series stationarity health 
                                                        
12
 A stationary time series is one whose mean and variance do not change with time. If variables in 
a regression are non-stationary, then the implication is that the regression may be spurious.  If the 
error term is stationary, then the two variables are co-integrated with the error term representing 
short term deviations from that relationship.  Tests for stationarity are available but their power is 
limited by both the quality and the time span of the data [33,34,35, 36] For studies of health 
expenditure determinants using this approach, see [37, 38, 39 ]. Stationarity may not be as serious 
a problem in panel data when panel level tests are employed and therefore "researchers studying 
national health expenditures need not be as concerned as previously thought about the presence of 
unit roots in the data." [40: 375]. 
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spending literature like the main body of literature find income elasticities of health 
care spending not significantly different from one. Recent work also concludes that 
meaningful results are possible in regular panel regression approaches if allowance 
is made for structural changes. (44: 322). 
 
Despite the focus on income as a health expenditure driver and the income elasticity 
of health spending, other factors have also come to assume a greater role in these 
studies.   Newhouse (45,46) regressed per capita medical expenditures on GDP per 
capita for 13 countries circa 1970 finding “over 90 percent of the variance in per 
capita medical expenditure in these countries can be explained by variation in per 
capita GDP” and that health care spending was income elastic with the elasticity 
ranging from 1.15 to 1.31.  (45: 117).   However, in later work, Newhouse argued 
health care spending was a normal good but income inelastic leading Newhouse to 
conjecture that a larger portion of the increase in health expenditures is due to other 
factors such as technological and demographic change including population aging 
[47].  
 
A variety of technological innovations have been held responsible for rising health 
expenditures including new medical techniques, treatments and pharmaceutical 
innovations.  For example, pharmaceuticals are substituted for other health services, 
including institutionalisation (with the introduction of anti-psychotics) and surgery 
(anti-ulcer drugs), and perhaps even the amount of time physicians spend with their 
patients [48].   Popular discussion has viewed aging populations –  in particular the 
proportion aged greater than 65 - as a major cost driver whereas academic studies 
often noted the impact of aging is overstated [49,50].  Along with age alone are the 
intertwined effects of changing health expectations and demands across population 
cohorts, the impact of new technologies, and age related changes on health service 
Determinants of Public Health Expenditures 
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costs such as the higher costs in the final days of life as proximity to death nears 
[51,52].13  
 
Indeed, the proportion of population aged 65 and over is a positive and significant 
driver of Canadian provincial government health spending when simple regression 
specifications are used but its effect becomes negative when more complex age 
specifications and time trend are included [27].   Reinhardt (53) notes that 
population aging is a minor cause of the annual growth in health care spending 
given rising incomes, expensive new health technology and labor costs that can raise 
per unit health care costs.  Morgan and Cunningham (54) found the effects of 
population aging small contributing less than 1% per year to spending with changes 
in age-specific mortality rates reducing hospital expenditure by –0.3% per year. 
 
As for micro and individual level regression studies, Brinda et al, (55) use a sample 
of 2,414 people aged 65 years and older from the WHO’s Study on Global Aging for 
India and find Out-of-pocket health expenditures were higher among participants 
with disabilities and lower income. Gopffarth et al., (56) use 2011 year data on 
expenditure, utilization of health services and state of health in Germany's statutory 
health insurance system by county.  They conclude that regional variation in 
German health expenditures can be explained to a large degree by variations in 
health and demography across counties. 
 
Finally, besides rising trends in health expenditure – and explanations for its 
particular growth differences across countries– during the last years had been 
concerned with the sustainability of national health-care systems and the 
decomposition of the drivers [57,58]. This issue had become interesting to economic 
researchers, and so a growing literature has recently risen [59,60,61]. 
 
                                                        
13
  For Canada a CIHI analysis of cost drivers focusing on the period 1998 to 2008 found that total public-
sector spending on health care increased at an average annual rate of 7.4% with population growth 
contributing an average of 1% per year to the increase in health expenditures, while population aging 
contributed only 0.8%, making demographic factors relatively modest contributors at 1.8%. See [10: xix]. 
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Summarizing the key variables and their effects on health care expenditures, Martin 
et al. [62] review the literature on health care expenditure determinants for the 
period 1998 to 2007 and find no clear patterns of results.  Of the studies they 
surveyed, about 20 percent found income to be the principal determinant while 30 
percent of studies highlighted population aging though another 30 percent 
highlighted the proximity to death.  Of these studies, only just over half calculate an 
income elasticity of health care spending and of those about one-fifth of them find 
an income elasticity greater than 1.  Martin et al., [62: 1] conclude that there is no 
consensus with respect to the variables to be used or the econometric specification 
employed when it comes to estimating health expenditure determinants in the 
OECD countries. Moreover, the evidence that population ageing is a major 
contributor is not definitive and other factors such as technological change, 
proximity to death and decentralization of service provision are seen as of 
increasing importance.  
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IV. Models and Data 
 
Data is available for 17 Spanish regions 2002 to 2013 [63] and for 10 Canadian 
provinces for the period 1981 to 2013 and used to run separate pooled time series 
cross-section regressions.  The time span for both countries is determined by the 
ready availability of consistent regional data series not just for health expenditure 
(which in Canada at the provincial level actually goes back to 1975) but also other 
economic and demographic variables such as GDP (which for Canada are more 
consistently and readily available back to the early 1980s).  For Spain, regional 
government is a relatively recent innovation and there have been institutional 
changes to the health care system and data series have not yet been substantially 
extended backwards in time.  Due to the nature and availability of the data collected, 
identically specified regressions for both were not possible but it was possible to 
include income, time trend, demographics, physician numbers and regional fixed 
effects in both regressions. 
 
Canada and Spain 
 
A pooled time-series cross-section regression14 model is estimated for provincial 
and/or regional government health expenditure category taking the form: 
 
(1) Hit = f(z1it, z2it, ….znit) 
 
where Hit is real per capita government health expenditures of the i-th 
province/region at period t, and z1 to zn represent a vector of social, demographic, 
economic and policy variables of the i-th province/region at time t which are 
determinants of Hit. These determinants are essentially expenditure-drivers and the 
literature has identified these key drivers to broadly include population growth, 
                                                        
14
 The pooled regression is preferable to single province/region estimates because pooling allows for a 
larger sample and more degrees of freedom.  
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population aging, income growth, inflation and enrichment factors such as 
technological change as accounted for by either time trend or residual effects [64].15  
 
Specifically, the determinants of real per capita government health spending are 
defined as physicians per 1,000 of population16, real per capita GDP, the proportion 
of population aged 65 years and over, real per capita federal cash transfers (for 
Canada only,17 a variable designed to capture federal transfer regime switches (for 
Canada only) 18 and time trend.  Inflation is accounted for in all these regressions by 
using real expenditure data (in 1997 dollars for Canada and 2010 euros for Spain). 
Finally, province/region dummies are also included in the regressions for the 
provinces to capture time invariant regional fixed effects not captured by other 
variables in the model.  
 
The inclusion of physician numbers is to take into consideration their impact on 
spending given their role as gatekeepers to the services of the health care system 
                                                        
15
 A time trend (YEAR) is often used to account for technological change’s impact.  If new techniques 
generate cheaper health procedures, there could be expenditure reductions associated with technological 
change. Cutler et al. report that between 1983 and 1994, the real quality-adjusted price of heart attack 
treatments declined at an annual rate of 1.1 percent.  At the same time, with new treatments, technological 
change can be associated with rising health expenditures [65].  
 
16
 The variable for physician numbers is the number of physicians per 1,000 people.  The intent is not to 
capture the effect of the total number of physicians on government health spending but the effect of 
physician deepening.  In other words, what is of interest is not extensive but intensive growth in physicians.  
See Di Matteo [3].   
 
17
 At present, Canadian federal cash transfers to the provinces and territories are provided in four main 
programs: the Canada Health Transfer (CHT), the Canada Social Transfer (CST), Equalization and the 
Territorial Formula Financing (TFF) for total federal cash transfer support in 2015-16 of 68 billion dollars. 
The Canada Health Transfer of cash to the provinces has grown steadily from $20.3 billion in 2005 and is 
expected to reach 34 billion in 2015-16 – an annual growth rate of nearly six percent.  It accounts for about 
half of federal cash transfers to the provinces. 
 
18
 In 1977, Established Program Financing (EPF) replaced federal-provincial cost sharing on health with a 
block grant.  In 1984 there was the onset of the Canada Health Act (CHA), which tied the receipt of federal 
transfers to running a health care system that met basic conditions. In 1996, EPF and the Canada Assistance 
Plan, which funded income support, were collapsed into one transfer (and the cash portion reduced by one-
third).  This new transfer was called the Canada Health and Social Transfer (CHST). Finally, in 2005 the 
CHST was broken up into two transfer payments – the Canada Health Transfer and the Canada Social 
Transfer. 
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and not as a test for supplier induced demand.19    The effect of supplier-induced 
demand can be more spending on physician services as a result of either increased 
volume or a higher equilibrium fee for services.  However, in the absence of specific 
data on physician fees and changes in fee schedules over time, physicians per capita 
in our regressions is not the best test for the effects of supplier induced demand and 
at best represents an attempt to capture the role of physician density as a 
gatekeeper to the access of health care services and determinant of expenditures.20  
 
The variables are defined for Canada in Table 1-a and the data for these regression 
variables were obtained from the National Health Expenditure database constructed 
by the Canadian Institute for Health Information21 and also from CANSIM-Statistics 
Canada and the Federal Fiscal Reference Tables (See Appendix I for a summary).  
 
In the same manner, the variables are defined for Spain in Table 1-b and the data for 
these regression variables were obtained from the BBVA Foundation and Ivie 
(Instituto Valenciano de Investigaciones Económicas) (2015) and also from Spanish 
National Institute of Statistics (See Appendix I for a summary).  
 
Canadian and Spanish regression results are presented in Table 2 using Generalized 
Least Squares (GLS) estimates for log-log specifications excluding and including 
                                                        
19
 Supplier induced demand may occur when health care providers use their superior knowledge to take 
advantage of the information gap between health care professionals and their patients and influence 
demand for the purposes of economic self-interest.  The classic expositions by Shain and Roemer (were 
applied to hospital spending [66,67].  They argued that hospital beds that are built are occupied regardless 
of whether there are few or many beds per capita. Their research found positive correlations between short-
term general hospital beds per 1000 population and hospital days per 1000 population. This phenomenon is 
described as: "a bed built is a bed filled" and the effect became known as Roemer's Law. 
 
20 The literature on supplier induced demand is quite substantial and not conclusive and the issue is still 
subject to considerable debate. See [68, 69, 70, 71, 72, 73, 74, 75, 76]. 
 
21
 Physician numbers were also obtained from the Canadian Institute for Health Information National 
Physician Database. 
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time trend.22 As well, GLS estimates are presented in an effort to deal with any 
autocorrelation or heteroscedasticity that might affect OLS estimates.23 The GLS 
estimates assumed heteroscedastic panels with a common AR(1) correlation for all 
panels.  Estimates were done using STATA 15 and similar testing was done on the 
data. 
 
For example, Levin-Lin-Chu and Fisher Type24 unit root tests for panel data were 
conducted for the variables in the data sets and the variables exhibited a high 
degree of stationarity25 with the null hypothesis of a unit root being rejected for 
many of the variables. In addition, when a correlation matrix was done for the 
variables in the final models, many of the correlation coefficients were below 0.5 
suggesting that the impact of multi-collinearity was limited in the estimates.  
 
 
 
 
                                                        
22
 These estimates are pooled time series cross sections using Generalized Least Squares (GLS), assuming 
heteroskedastic panels with cross-sectional correlation and common ar (1). As well, linear and log-linear 
specifications were also estimated, and their results parallel the log-log ones. 
 
23
 Inspection of plots of residuals against the regression variables did not show heteroscedastic patterns. 
Box-Cox testing found a linear specification to be more suitable than log-linear.  However, the linear and 
log-linear results paralleled the log-log ones in terms of both magnitude and significance and log-log results 
presented in order to show elasticities. As well, a Ramsay-Rest test on the variables used in the Box-Cox 
test that the model has no omitted variables did not support the presence of omitted variables. Nonetheless, 
the omission of explanatory variables or the use of an incorrect functional form can also lead to the 
conclusion that autocorrelation or heteroscedasticity is present. A common practice is to use a generalized 
least squares technique (GLS) to construct additional estimates. [77]   
 
24
 The Levin–Lin–Chu test requires that the ratio of the number of panels to time periods tend to zero 
asymptotically and does not suit datasets with a large number of panels and relatively few time periods.  
This data set has a small number of panels (10) and a fixed number of time periods.  The Levin-Liu-Chu 
tests were done with trend assumed. The Fisher-Type tests assumed the dfuller option, drift and two lags 
and were done both with and without the demean option.  It should be noted that panel test outcomes are 
often difficult to interpret if the null of the unit root is rejected and the best that can often be concluded is 
that “a significant fraction of the cross section units is stationary or cointegrated”. [78]. 
 
25
 A stationary time-series is one whose mean and variance do not change with time. If variables in a 
regression are non-stationary, then the implication is that the regression may be spurious. Tests for 
stationarity are available but their power can be limited by both the quality and the time span of the data. 
See [34,36]. Some research has suggested that stationarity may not be as serious a problem in panel data 
when panel level tests are employed. See  [39, 40] 
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V. Results and discussion 
 
 
Much in line with results from other studies, the results for Canada and Spain show 
that physicians per 1,000 population, real per capita GDP and time trend were all 
positive drivers of real per capita government health expenditures.  Real per capita 
GDP and time trend were statistically significant positive drivers for both countries 
whereas physician numbers were only significant for Canada.  With respect to time 
trend, after controlling for confounding factors, each year saw an average annual 
increase of 1.6 percent for Canada and 3.2 percent for Spain.   
 
As well, real per capita public health spending was quite income inelastic for both 
countries in the estimates without time trend but once time trend was included 
Spain’s health spending became more income elastic.  Overall, Spain exhibited 
greater income elasticity of health spending than Canada.  Canada’s income 
elasticity of health spending ranged from 0.28 to 0.52 whereas Spain’s ranged from 
0.84 to 1.2.  Spain’s higher income elasticity means that its public health spending 
would be much more sensitive to income.  Even when federal cash transfers, which 
are a form of income, are considered with respect to Canada the elasticity is quite 
small though the coefficients are significant. 
 
Average real per capita income in this data set was $37,771 for Canada and 24,023 
Euros for Spain. Again, using the results from the regressions including time trend, a 
one percent increase in real per capita GDP – an increase of about $378 would 
increase real per capita government health spending in Canada by approximately 
0.28 percent for an increase of about $5.50 in real per capita provincial government 
health spending.  On the other hand, for Spain, an increase in real per capita income 
of 1 percent – or about 240 Euros – would increase real per capita government 
health spending by 1.19 percent or approximately 26 Euros.   
 
It should be noted that between 2002 and 2013, average real per capita income in 
the Spanish data set actually declined by 7 percent primarily as a result of the 
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impact of the global financial crisis Great Recession while for Canada – which 
weathered the crisis well relative to other G7 countries - it grew 14 percent.  Over 
the period 2002 to 2013, the increase in real per capita GDP alone would have 
resulted in an increase in average provincial government health spending in Canada 
of 4 percent compared to a decline in Spain of 8 percent.  Thus, one reason for the 
difference between Canadian and Spanish per capita public health spending is 
directly tied to the differential performance of income combined with the higher 
income elasticity of Spanish health spending. 
 
As for the aging variables, for Canada, the proportion of population aged 65 years 
and over was not a positive driver of health spending once time trend was 
controlled for.26  However, it was negative and significant for Spain both with and 
without the time trend.  These results are in keep with recent revisionist literature 
on the impact of age on health spending and it supports the case for a more 
complicated impact of aging on health care spending than popularly assumed. While 
aging is still seen as a factor in rising health expenditures, its contribution has 
recently been determined to be relatively small compared to factors such as rising 
care expectations, time to death, rising input prices and technological extension.27   
 
Furthermore, for Canada, health spending is quite inelastic with respect to the 
proportion aged 65 and over and with an increase in the proportion from 10.1 
percent to 15.8 percent between 1981 and 2013, the predicted decline in spending 
attributable to population aging would have been quite small.  It should be noted 
that using the regression without a time trend, health spending is positively affected 
by an aging population but still quite inelastic with respect to the proportion aged 
65 years and over and as a result in that specification barely a fifth of the increase in 
real per capita spending would be attributable to aging – with physicians and 
                                                        
26
 It should be noted that this result held when a more complicated age structure was used for Canada 
breaking the data up into age groups 0-24, 25 to 44, 45 to 64 and 65 and over.  However, what was positive 
and significant in this case was the proportion of population aged 45 to 64. 
27
 For other discussions of this, see [79,80,81].  
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income being larger in their impact.  In the case of Spain, spending is more elastic 
with respect to an aging population, but the proportion aged 65 and over did not 
increase substantially between 2002 and 2013 – going only from 17 to 18 percent – 
and therefore again would not have been as significant a factor in affecting Spanish 
public health expenditures.  
 
The lack of importance of the proportion of the population aged 65 years and over is 
also a function of the fact that aging may be correlated with variables such as 
income as well as the time trend and the true impact of aging is intertwined with 
these variables.  Moreover, the observation needs to be made that while populations 
are aging, both Canada and Spain have seen a slowdown in the growth rate of real 
per capita public health spending with Spain witnessing as actual decline since 
2008.  Given the relatively short time span of the Spanish data from 2002 to 2013 
which is marked by an aging population, falling real per capita GDP and public 
health spending after 2008, any negative correlation between aging and health 
spending is not surprising and may be an artefact of the shorter time span and its 
unique events. 
 
The province/regional variables show that in both countries there is some 
statistically significant regional variation in spending with the variations more 
pronounced in Spain.  When time trend is included for Canada, compared to Ontario 
(the omitted province), real per capita spending is 4 percent less in Quebec and 11.5 
percent less in Alberta but 10.5, 8.4 and 8.1 percent more in Prince Edward Island, 
Saskatchewan and British Columbia respectively.  For Spain, compared to Madrid 
(the omitted region), real per capita spending is significantly higher in all the other 
regions ranging from only 25 percent higher in Balears to 136 percent more in 
Extremadura. 
 
With respect to the impact of physicians, total physicians per 1,000 were only 
statistically most significant (at the 5 percent level) for Canada and not significant 
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for Spain.28  A 1 percent increase in physicians per 1000 in Canada would increase 
provincial government health spending by 0.29 to 0.35 percent making spending 
relatively inelastic to the number of physicians per 1,000.  While physician numbers 
for Spain were not significant, they were even more inelastic than Canada at about 
0.02 percent. 
 
In 1981, average physicians per 1,000 in Canada across the ten provinces were 1.41 
and rose to 2.21 in 2013 – an increase of 81 percent.  In Spain, between 2002 and 
2013, the average number of physicians across the 17 regions rose only slightly 
from 6.26 to 6.27.  The average number of physicians per 1000 in these data sets 
were 1.8 for Canada and 6.3 for Spain.    Using the results from the regressions 
including time trend, adding one physician per 1,000 of population would increase 
real per capita government health spending in Canada by approximately 16.2 
percent or $316. For Spain, adding one physician per 1,000 population would 
increase real per capita health spending by 0.3 percent or about 41 Euros. Given the 
average real per capita public health spending in these data sets was $1,953 ($1997) 
for Canada and 1375 Euros (2010 Euros) for Spain, physician numbers in Canada 
are a more important contributor to spending.    
 
  
                                                        
28
 Given the availability of a breakdown into GPs and Specialists, the model was also run for Canada using 
these two variables rather than total physicians and it was found that it was Specialists per 1,000 that was 
positive and statistically significant.  This of course raises the possibility that specialist numbers in 
particular may be a proxy for hospital costs since in Canada only care delivered in hospitals or by 
physicians is publicly paid for creating an incentive for people to be treated in hospitals. 
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 Table 1-a: Regression Variables, Canada 
 
Dependent Variables 
 
Real per capita provincial government total health expenditures in 1997 
dollars deflated using the Government current expenditure implicit Price 
Index. Source: Canadian Institute for Health Information, NHEX. 
 
Independent Variables 
 
Number of total physicians per 1000 population. 
 
Real per capita gross domestic product in 2007 dollars. Deflated using the GDP 
Deflator, 2007=100.  
 
Real per capita federal cash transfer revenues. In 1997 dollars, deflated using 
the Government Current Expenditure Implicit Price Index. 
 
Proportion of population aged 65 or greater 
 
1 if Newfoundland & Labrador, 0 otherwise. 
1 if Prince Edward Island, 0 otherwise 
1 if Nova Scotia, 0 otherwise. 
1 if New Brunswick, 0 otherwise. 
1 if Quebec, 0 otherwise. 
1 if Ontario, 0 otherwise. 
1 if Manitoba, 0 otherwise. 
1 if Saskatchewan, 0 otherwise. 
1 if Alberta, 0 otherwise. 
1 if British Columbia, 0 otherwise. 
 
Canada Health and Social Transfer. 1 if combined Canada Health and Social 
Transfer in effect (1996-2004), 0 otherwise. 
 
Year (defined as a time indicator variable running from 1 to 33) 
 
 
  
Determinants of Public Health Expenditures 
 28 
Table 1-b: Regression Variables, Spain 
 
Dependent Variables 
 
Real per capita provincial government total health expenditures in Euros 
deflated. Source:  BBVA Foundation and Ivie (Instituto Valenciano de 
Investigaciones Económicas) (2015). 
 
Independent Variables 
 
Number of total physicians per 1000 population. Source: Spanish Institute of 
Statistics 
 
Real per capita gross domestic product in 2010 euros. Source: Spanish  
Institute of Statistics 
 
Proportion of population aged 65 or greater. 
 
1 if Andalucia, 0 otherwise. 
1 if Aragón, 0 otherwise 
1 if Asturias, 0 otherwise. 
1 if Balears Islands, 0 otherwise. 
1 if Canarias, 0 otherwise. 
1 if Cantabria, 0 otherwise. 
1 if Castilla and Leon, 0 otherwise. 
1 if Castilla-La Mancha, 0 otherwise. 
1 if Cataluña, 0 otherwise. 
1 if Region of Valencia, 0 otherwise. 
1 if Extremadura, 0 otherwise 
1 if Galicia, 0 otherwise. 
1 if Madrid, 0 otherwise 
1 if Murcia, 0 otherwise. 
1 if Navarra, 0 otherwise 
1 if Basque Country, 0 otherwise. 
1 if La Rioja, 0 otherwise 
 
Year (defined as a time indicator variable) 
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Table 2: Regression Results, Canada & Spain 
Estimation Technique: Cross-sectional time series FGLS, heteroskedastic, 
common AR(1) 
 
a) Canada 
Dependent Variable     
Log of Real Per Capita provincial government health expenditures 
(dollars) 
 
     
 Log-Log A  Log-Log B  
 Coefficient z Coefficient Z 
Log of Total Physicians per 1,000 0.3508 4.67 0.2926 4.33 
Log Real Per Capita GDP 0.5254 9.37 0.2765 4.80 
Log Real Per Capita Federal 
Transfers 
0.0614 3.92 0.0466 3.29 
Log of Proportion Aged 65 and Over 0.3493 3.99 -0.2561 -2.71 
Newfoundland & Labrador 0.0239 0.66 -0.0351 -0.99 
Prince Edward Island 0.1281 2.41 0.1050 2.23 
Nova Scotia -0.0413 -1.05 -0.0270 -0.76 
New Brunswick 0.0804 2.04 0.0546 1.58 
Quebec -0.0092 -0.32 -0.0395 -1.55 
Manitoba 0.0445 1.29 0.0773 2.86 
Saskatchewan -0.0037 -0.10 0.0842 2.56 
Alberta -0.0615 -1.11 -0.1150 -2.35 
British Columbia 0.0335 1.37 0.0807 3.82 
Canada Health & Social Transfer 0.0124 1.12 -0.0245 -2.31 
Time Trend   0.0156 9.99 
Constant 2.0999 3.00 3.3443 5.20 
     
Observations 330  330  
Wald chi2 1153  1555  
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b)  Spain 
 
Dependent Variable     
Log of Real Per Capita regional government total health expenditures (euros) 
     
 Log-Log A  Log-Log B  
 Coefficient z Coefficent Z 
Log of Total Physicians per 1,000 0.0163 0.30 0.0187 0.50 
Log of Real Per Capita GDP 0.8385 5.00 1.1999 11.70 
Log of Proportion Aged 65 and Over -0.8081 -2.10 -1.2722 -5.38 
Andalucia 0.4825 4.21 0.6903 10.82 
Aragon 0.6168 4.73 0.8436 10.79 
Asturias 0.9222 5.93 1.2559 13.48 
Balears 0.1916 2.01 0.2526 4.91 
Canarias 0.3552 2.62 0.4477 5.83 
Cantabria 0.7207 6.69 0.9649 14.72 
Castilla and Leon 0.8029 4.93 1.1403 11.65 
Castilla-La Mancha 0.7226 6.39 1.0145 14.55 
Cataluna 0.3145 3.86 0.4198 10.08 
Valencia 0.4852 5.00 0.6838 12.94 
Extremadura 0.9855 7.76 1.3616 18.01 
Galicia 0.8379 5.75 1.1860 13.52 
Murcia 0.5096 4.19 0.6605 9.93 
Navarra 0.4329 4.60 0.5468 10.53 
Basque 0.4988 4.22 0.6317 9.76 
La Rioja 0.5659 4.86 0.7591 11.03 
Time Trend   0.0315 17.71 
Constant 0.4799 0.20 -2.2277 -1.51 
     
Observations 204  204  
Wald chi2 98  637  
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VI. Conclusion 
 
Canada spends considerably more per capita on health than Spain while basic health 
outcome indicators suggest that the performance of Spain’s health care system has 
improved more than Canada’s.  Canada’s health spending is generally more income 
inelastic than Spain’s and its income elasticity of health spending ranged from 0.28 
to 0.52 whereas Spain’s ranged from 0.84 to 1.2.  An important difference between 
Canada and Spain in terms of their economies is Canada’s higher per capita GDP 
which can partially explain the gap in spending.  Moreover, given that Canada’s real 
per capita GDP has grown since 2002 while Spain’s has declined, is an important 
factor explaining the difference in real per capita health spending between the two 
countries.   
 
Another difference is in physician intensity – that is, Canada has fewer physicians 
per capita than Spain but here we find that physician numbers are a more 
statistically significant driver of real per capita provincial government health 
expenditures in Canada but not in Spain despite the fact that the per capita number 
of physicians is greater in Spain.  Indeed, physician density has grown in Canada 
since 2002 while in Spain it has remained stable.  
 
Adding one physician per 1,000 of population would increase real per capita 
government health spending in Canada by approximately 16.2 percent or $316.  For 
Spain, adding one physician per 1,000 population would increase real per capita 
health spending by 0.3 percent or about 41 Euros.   Between 2002 and 2013, the 
average regional number of physicians per 1,000 population in Spain has remained 
flat whereas in Canada it has grown from 1.79 to 2.21. 
 
As for aging, aging per se – that is the effect of seniors – is not a significant positive 
driver of spending in either Canada or Spain suggesting the impact of age on health 
spending is a more complicated phenomenon than popular discussion would 
suggest.  The proportion of population aged 65 and over is often negatively 
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correlated with real per capita provincial government spending when variables like 
time trend and income are included suggesting any positive effects of aging on 
health spending are intertwined with these variables.  Meanwhile, technological 
change, as measured by time trend appears to be a greater driver of spending for 
Spain than for Canada with an average annual increase in spending of 3.2 percent 
annually compared to 1.6 in Canada. 
 
From a policy perspective, there seem to be interesting lessons here for 
international public health care systems.   First, the relative size and strength of 
expenditure drivers differs between these two countries and explains much of the 
difference between Canada and Spain when it comes to real per capita health 
spending.  Canada – relative to Spain – has seen greater growth in both physicians 
per 1,000 population as well as real per capita GDP – both factors of significant 
importance when it comes to driving health spending.  While the effects of time are 
greater in Spain than Canada in terms of impact on annual spending increases, they 
have not been sufficient to overcome the gap between Canadian and Spanish real 
per capita public health spending. 
 
Second, when it comes to health outcomes, more spending per se does not 
necessarily translate into greater health outcomes at least in terms of the macro 
level health indicators used here. With respect to public health care spending, 
Canada spends approximately 48 percent more than Spain and yet by 2012 life 
expectancy at birth in Spain was 1.3 percent higher and infant mortality 35 percent 
lower in Spain. This would suggest that given value for money, the Spanish health 
care system is able to deliver a more cost-effective performance at least when it 
comes to these basic health indicators.   
 
Notwithstanding the potential impact of other socio-economic determinants on 
health status, this raises the question of what Canada can do more efficiently in 
running its public health systems given its provinces are spending substantially 
more than Spanish regions. One factor here is the response of health spending to 
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physician numbers given that Canadian health spending is more elastic to physician 
numbers and has seen greater growth in physician numbers in recent years.  Indeed, 
the institutional structure and differences of physician behaviour in these two 
countries may be factors worth examining more carefully as might be the funding 
mechanisms of their respective government systems.29 
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29
 In the context of Canadian federalism, equalization and transfers, there may indeed be additional 
interplay with effects on health spending.[82] 
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